Management of High Blood Pressure in Blacks

Citations Over TimeTop 1% of 2010 papers

Abstract

Since the first International Society on Hypertension in Blacks consensus statement on the "Management of High Blood Pressure in African American" in 2003, data from additional clinical trials have become available. We reviewed hypertension and cardiovascular disease prevention and treatment guidelines, pharmacological hypertension clinical end point trials, and blood pressure-lowering trials in blacks. Selected trials without significant black representation were considered. In this update, blacks with hypertension are divided into 2 risk strata, primary prevention, where elevated blood pressure without target organ damage, preclinical cardiovascular disease, or overt cardiovascular disease for whom blood pressure consistently 15/10 mm Hg above target, 2-drug therapy is recommended, with either a calcium channel blocker plus a renin-angiotensin system blocker or, alternatively, in edematous and/or volume-overload states, with a thiazide diuretic plus a renin-angiotensin system blocker. Effective multidrug therapeutic combinations through 4 drugs are described. Comprehensive lifestyle modifications should be initiated in blacks when blood pressure is ≥115/75 mm Hg. The updated International Society on Hypertension in Blacks consensus statement on hypertension management in blacks lowers the minimum target blood pressure level for the lowest-risk blacks, emphasizes effective multidrug regimens, and de-emphasizes monotherapy.

Related Papers

• → Blood Pressure Variability and Classification of Prehypertension and Hypertension in Adolescence(2008)202 cited
• → Blood pressure to height ratio as a screening tool for prehypertension and hypertension in adolescents(2016)23 cited
• → How do thiazide and thiazide-like diuretics lower blood pressure?(2004)84 cited
• → Thiazide and Thiazide-Like Diuretics in Therapy of Arterial Hypertension(2019)4 cited
• Prehypertension--a hidden risk of Indian subcontinent.(2013)